A Promising New Target for Treating Lissencephaly: A Molecular Breakthrough
Lissencephaly, a rare and devastating group of genetic disorders, affects brain development, causing a lack of normal folds and leading to seizures and intellectual disability. Sadly, there are currently no effective treatments available. However, a groundbreaking new study from Yale University offers a glimmer of hope.
Understanding Lissencephaly
Lissencephaly falls under a category called malformations of cortical development. This means the normal formation and structure of the brain are disrupted, often due to mutations in genes crucial for brain development.
“Lissencephaly belongs to a group of disorders we call malformations of cortical development, meaning the normal development and structure of the brain is disrupted. They come about because certain genes that are very important for brain development are affected by rare mutations,” explains Dr. Angeliki Louvi, Professor of Neurosurgery and of Neuroscience at Yale School of Medicine and co-senior author of the study.
A Novel Discovery Unveiled
Through years of dedicated research, the Yale Program in Neurogenetics, led by Dr. Murat Gunel and Dr. Kaya Bilguvar, has made significant strides in understanding the genetic basis of lissencephaly. By collecting blood samples from affected patients, they have identified numerous genes linked to the disorder.
This latest study takes a significant leap forward. Researchers not only identified a new gene associated with lissencephaly but also found a way to recreate the disorder in the lab using mini-brains called organoids. Organoids are three-dimensional models of developing brains grown from patient cells, allowing scientists to study brain development in unprecedented detail.
The mTOR Pathway: A Key Player in Brain Development
Using these organoids, the researchers discovered a crucial clue: an underperforming mTOR pathway. The mTOR pathway is a vital cellular pathway responsible for regulating various aspects of cell growth and metabolism, playing a critical role in healthy brain development. In lissencephaly cases, the researchers found that this pathway was not functioning correctly, leading to the characteristic brain abnormalities.
“This is a fundamental pathway that governs many different aspects of cellular metabolism to maintain cellular homeostasis,” said Dr. Louvi. “And we know of many disorders in which the mTOR pathway is overactive, but here we found that in lissencephaly it’s actually underperforming.”
A Potential Treatment on the Horizon?
The exciting news is that researchers were able to reverse these brain abnormalities by boosting the activity of the mTOR pathway using a drug. This finding could potentially pave the way for new treatments for lissencephaly, offering hope to patients and families worldwide.
“Right now, in medicine we have no way to slow or reverse these structural brain malformations in lissencephaly either during pregnancy or after,” says Dr. Ce Zhang, lead author of the study who was an M.D.-Ph.D. student in the Bilguvar and Louvi labs. “That limits us to treating the symptoms, but even that can be difficult, as lissencephaly seizures may not be well-controlled using typical anti-epileptic drugs.” The researchers believe that targeting the mTOR pathway could hold the key to correcting these malformations and significantly improving the lives of individuals with lissencephaly.
Future Directions
While the findings are promising, more research is needed to fully understand the role of the mTOR pathway in lissencephaly and to explore its potential as a therapeutic target. Future studies will focus on:
- Determining if the mTOR pathway is implicated in other genetic types of lissencephaly.
- Investigating the precise molecular mechanisms by which an underactive mTOR pathway leads to lissencephaly.
- Exploring the potential clinical applications of mTOR activators in treating lissencephaly.
Join the Fight for a Cure
Lissencephaly is a complex and challenging disorder, but this groundbreaking research provides a beacon of hope. By supporting research and raising awareness, we can work together to find effective treatments and ultimately cure this devastating disease.
The post Yale study identifies molecular mechanism behind some lissencephaly disorders. appeared first on Archynewsy.